European marketing authorization follows U.S. FDA clearance of eyonis LCS, Median's AI-based Software as a Medical Device designed to aid in the detection and diagnosis of lung cancer in screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results